Literature DB >> 21107828

Consumption of non-steroidal anti-inflammatory drugs in Serbia: a comparison with Croatia and Denmark during 2005-2008.

Vesna Mijatović1, Jelena Calasan, Olga Horvat, Ana Sabo, Zdenko Tomić, Vukašin Radulović.   

Abstract

PURPOSE: To analyze the amount and pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) in Serbia and to compare these parameters with those in Croatia and Denmark. The prescribing pattern of NSAIDs in Serbia as a direct indicator of physicians' knowledge of these agents was also assessed.
METHODS: The use of NSAIDs in Serbia, Croatia, and Denmark was analyzed during a 4-year period (2005-2008). Data were retrieved from the annual reports of the Agency for Drugs and Medical Devices of Serbia, Croatia, and Denmark. Data on prescribing behavior were obtained from the Health Insurance Fund of Serbia and represent NSAIDs issued by prescription between 2005 and 2008. Results were expressed as the number of defined daily doses/1000 inhabitants/day. The drug utilization 90% method was also used.
RESULTS: The total consumption of NSAIDs in Serbia was higher than that in Croatia and Denmark. Diclofenac accounted for approximately 50% of NSAID consumption during the observation period, followed (in much smaller quantities) by ibuprofen. The most commonly prescribed medicine was diclofenac, followed, in much smaller amounts, by ibuprofen. There was no trend of a reduced consumption of diclofenac or of an increased use of ibuprofen during the study period
CONCLUSIONS: These data suggest that factors other than evidence-based medicine have a dominant effect on the use of NSAIDs in Serbia. Targeted education from independent sources in the prescribing, dispensing, and use of drugs is important to improve the quality of the prescribing behavior and the use of NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21107828     DOI: 10.1007/s00228-010-0951-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

1.  Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information.

Authors:  András Inotai; Balázs Hankó; Agnes Mészáros
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-02       Impact factor: 2.890

2.  Comparison of NSAID consumption in Slovakia, Finland and Norway.

Authors:  R Hudec; M Kriska; L Bozekova; V Foltan
Journal:  Bratisl Lek Listy       Date:  2008       Impact factor: 1.278

3.  Drug utilization 90%--a simple method for assessing the quality of drug prescribing.

Authors:  U Bergman; C Popa; Y Tomson; B Wettermark; T R Einarson; H Aberg; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1998-04       Impact factor: 2.953

Review 4.  Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

Authors:  Patricia McGettigan; David Henry
Journal:  JAMA       Date:  2006-09-12       Impact factor: 56.272

Review 5.  The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs: a review of the literature.

Authors:  C Hawkins; G W Hanks
Journal:  J Pain Symptom Manage       Date:  2000-08       Impact factor: 3.612

6.  Diclofenac and ketoprofen liver toxicity in rat.

Authors:  Zdenko Tomic; Boris Milijasevic; Ana Sabo; Lalosevic Dusan; Vida Jakovljevic; Momir Mikov; Satman Majda; Velibor Vasovic
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

7.  Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).

Authors:  Vera Vlahovic-Palcevski; Björn Wettermark; Ulf Bergman
Journal:  Eur J Clin Pharmacol       Date:  2002-04-26       Impact factor: 2.953

8.  Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?

Authors:  T-P van Staa; S Rietbrock; E Setakis; H G M Leufkens
Journal:  J Intern Med       Date:  2008-06-25       Impact factor: 8.989

Review 9.  Prevention of NSAID-induced gastroduodenal ulcers.

Authors:  A Rostom; C Dube; G Wells; P Tugwell; V Welch; E Jolicoeur; J McGowan
Journal:  Cochrane Database Syst Rev       Date:  2002
  9 in total
  7 in total

1.  Storage and disposal of unused medications: knowledge, behavior, and attitudes among Serbian people.

Authors:  Milica P Kusturica; Ana Sabo; Zdenko Tomic; Olga Horvat; Zdravko Solak
Journal:  Int J Clin Pharm       Date:  2012-05-30

2.  Non-steroidal anti-inflammatory drugs and antibiotics prescription trends at a central west bank hospital.

Authors:  Yasin I Tayem; Marwan M Qubaja; Riyad K Shraim; Omar B Taha; Imadeddin A Abu Shkheidem; Murad A Ibrahim
Journal:  Sultan Qaboos Univ Med J       Date:  2013-11-08

3.  The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.

Authors:  Jelena Calasan; Vesna Mijatović; Olga Horvat; Jan Varga; Ana Sabo; Nebojša Stilinović
Journal:  Int J Clin Pharm       Date:  2011-02-25

4.  National consumption of opioid and nonopioid analgesics in Croatia: 2007-2013.

Authors:  Darko Krnic; Andrea Anic-Matic; Svjetlana Dosenovic; Pero Draganic; Sasa Zezelic; Livia Puljak
Journal:  Ther Clin Risk Manag       Date:  2015-08-28       Impact factor: 2.423

5.  How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England.

Authors:  Chiamaka Chiedozie; Mark E Murphy; Tom Fahey; Frank Moriarty
Journal:  BMJ Open       Date:  2021-03-02       Impact factor: 2.692

6.  Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study.

Authors:  Skaistė Kasciuškevičiūtė; Gintautas Gumbrevičius; Aušra Vendzelytė; Arūnas Ščiupokas; Kęstutis Petrikonis; Edmundas Kaduševičius
Journal:  Medicina (Kaunas)       Date:  2018-05-11       Impact factor: 2.430

7.  Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study.

Authors:  Inés Gómez-Acebo; Trinidad Dierssen-Sotos; María de Pedro; Beatriz Pérez-Gómez; Gemma Castaño-Vinyals; Tania Fernández-Villa; Camilo Palazuelos-Calderón; Pilar Amiano; Jaione Etxeberria; Yolanda Benavente; Guillermo Fernández-Tardón; Inmaculada Salcedo-Bellido; Rocío Capelo; Rosana Peiró; Rafael Marcos-Gragera; José M Huerta; Adonina Tardón; Aurelio Barricarte; Jone-Miren Altzibar; Jessica Alonso-Molero; Verónica Dávila-Batista; Nuria Aragonés; Marina Pollán; Manolis Kogevinas; Javier Llorca
Journal:  BMC Public Health       Date:  2018-09-21       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.